cyan Valuation
Is CYR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CYR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CYR (€0.98) wird unter unserer Schätzung des Fair Value (€2.85) gehandelt.
Significantly Below Fair Value: CYR wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CYR?
Other financial metrics that can be useful for relative valuation.
| What is CYR's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | €19.45m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.6x |
| Enterprise Value/EBITDA | -1.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CYR's PS Ratio compare to its peers?
| Company | PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 8.9x | ||
EXL Exasol | 2.6x | 16.4% | €89.9m |
IVU IVU Traffic Technologies | 2.1x | n/a | €238.1m |
IXX init innovation in traffic systems | 1.5x | 13.6% | €305.2m |
R1B Rubean | 29.6x | 41.0% | €19.0m |
CYR cyan | 2.4x | 25.3% | €19.5m |
Price-To-Sales vs Peers: CYR ist ein guter Wert, wenn man sein Price-To-Sales Verhältnis (2.5x) mit dem Durchschnitt der anderen Unternehmen (9.3x) vergleicht.
Price to Earnings Ratio vs Industry
How does CYR's PE Ratio compare vs other companies in the DE Software Industry?
Price-To-Sales vs Industry: CYR ist teuer, wenn man sein Price-To-Sales Verhältnis (2.6x) mit dem German Software Branchendurchschnitt (1.9x) vergleicht.
Price to Sales Ratio vs Fair Ratio
What is CYR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 2.4x |
| Fair PS Ratio | 1.1x |
Price-To-Sales vs Fair Ratio: CYR ist teuer auf der Grundlage des Verhältnisses Price-To-Sales (2.6x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Sales (1.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €1.03 | €3.05 +196.1% | 4.9% | €3.20 | €2.90 | n/a | 2 |
| Jan ’25 | €1.05 | €3.05 +190.5% | 4.9% | €3.20 | €2.90 | n/a | 2 |
| Dec ’24 | €1.18 | €3.25 +175.4% | 10.8% | €3.60 | €2.90 | n/a | 2 |
| Nov ’24 | €1.22 | €3.25 +166.4% | 10.8% | €3.60 | €2.90 | n/a | 2 |
| Sep ’24 | €1.84 | €3.75 +103.8% | 4.0% | €3.90 | €3.60 | n/a | 2 |
| Aug ’24 | €1.81 | €4.00 +121.0% | 10.0% | €4.40 | €3.60 | n/a | 2 |
| Jul ’24 | €1.95 | €4.00 +105.1% | 10.0% | €4.40 | €3.60 | n/a | 2 |
| Jun ’24 | €1.69 | €4.00 +136.7% | 10.0% | €4.40 | €3.60 | n/a | 2 |
| May ’24 | €1.60 | €4.75 +196.9% | 7.4% | €5.10 | €4.40 | n/a | 2 |
| Apr ’24 | €1.46 | €4.75 +226.5% | 7.4% | €5.10 | €4.40 | n/a | 2 |
Analyst Forecast: Das Kursziel liegt mehr als 20% über dem aktuellen Aktienkurs, aber es gibt nicht genügend Analysten, die die Aktie beobachten, um eine statistische Sicherheit für eine Übereinstimmung zu ermitteln.